Introduction {#s0005}
============

The tobacco market has changed dramatically, with cigarette use declining and the use of other tobacco products expanding ([@bb0045]). In particular, e-cigarette use has risen significantly and is especially high among adult smokers ([@bb0030]). The tobacco control community has begun to shift messaging from a traditional "all tobacco is equally bad" approach to one distinguishing a risk continuum, with some focus on e-cigarettes ([@bb0020]). This messaging shift has been directed not only at consumers, but also at physicians who treat tobacco users. A recent article in the *New England Journal of Medicine* stated that although the long-term effects of e-cigarette use are not known, these devices are "probably much safer than combustible tobacco products" ([@bb0010]). Likewise, the 50th anniversary issue of the Surgeon General\'s Report suggested that less risky cigarette substitutes, such as e-cigarettes, might contribute to the reduction of tobacco-caused disease ([@bb0045]). However, harm reduction and e-cigarettes in particular are not without controversy ([@bb0050]). Some researchers point to the lack of safety and efficacy data for the product and because nicotine is addictive, many health professionals remain opposed to its use ([@bb0015], [@bb0035]). Consequently, the public receives mixed messages about e-cigarettes, even among experts. Given the role physicians play as a trusted and credible source of health information, smokers are likely asking their physicians about these products ([@bb0040]). Although the research literature on physician communication regarding e-cigarettes is scant, it suggests that discussions are taking place in the clinical setting and some physicians are even recommending e-cigarettes to their patients as a smoking cessation aid ([@bb0025]). Given the paucity of data and the explosive growth of e-cigarettes, a pilot study was conducted to investigate e-cigarette physician--patient communication.

Methods {#s0010}
=======

We targeted a quota sample of 150 physicians who treat adults and released sample until the quota was met. The sampling frame was obtained from Jubilant Marketing Solutions, a firm that maintains e-mail lists of US physicians for direct marketing. Between January and April 2014, participants were e-mailed a link to a short web-based survey and received a \$10 Starbucks gift card for participation. Given the large number of e-mails that were non-deliverable (e.g., the physician no longer works for organization, the e-mail address does not exist), calculating an accurate response rate was problematic. The survey addressed demographics, including physician characteristics (e.g., specialty), whether patients had asked about e-cigarettes, whether the physician recommended e-cigarettes, and attitudes towards tobacco harm reduction. Data were analyzed using logistic regression; crude and adjusted odds ratios are presented.

Results {#s0015}
=======

Nearly 2 of 3 (65%) physicians reported being asked about e-cigarettes by their patients, and almost a third (30%) reported that they have recommended e-cigarettes (see [Table 1](#t0005){ref-type="table"}). In addition, more than a third (36%) endorsed a harm-reduction approach rather than a traditional "all tobacco is bad" position. Patient inquiry about e-cigarettes significantly increased over the course of the study (March/April vs. January/February), and was higher among physicians who always assess smoking status. In addition, male physicians were more likely to recommend e-cigarettes and endorse a harm-reduction approach. Physicians who treat tobacco-caused disease (e.g., oncologists, pulmonologists, cardiologists) generally had more e-cigarette inquiries and a harm-reduction orientation, as were those who graduated medical school after 1990, but these were not statistically significant.

Discussion {#s0020}
==========

These findings demonstrate that many patients ask their physicians about e-cigarettes, and despite a lack of scientific support, many physicians recommend them. This is consistent with results from a survey of North Carolina physicians in which nearly half reported that patients ask about e-cigarettes sometimes or often and a third recommended them to their patients for cessation ([@bb0025]). With a shift in perceptions from an "all tobacco is bad" approach to a broader harm-reduction understanding, as endorsed by 36% of physicians in our sample, the opportunity for physicians to consider smoking alternatives, such as e-cigarettes, has emerged.

This study is subject to limitations. First, the direct email list did not contain all physicians and was largely a sample of convenience, which limits generalizability. Second, the quality of the list was problematic (e.g., numerous emails were returned as "not deliverable"). While this makes calculating a response rate difficult, we estimated a minimum response rate of 2.25%. Although low, this is comparable to other physician email surveys with higher quality samples. Indeed, [@bb0005], using the American Medical Association Masterfile, conducted a physician email survey and achieved a 2% response rate with 5 email contacts (invite + 4 reminders) and no incentives; a \$50 incentive resulted in a slightly improved, but still low response rate of 7.4% (2011). While physician email surveys are less than ideal for generalizable data, they have an appropriate role to gather pilot data in a timely fashion. This sample is valuable in that it establishes that patients are asking about e-cigarettes and that responses to questions about the products are not uniform among physicians.

Despite patients asking physicians about e-cigarettes, the scientific community has limited data regarding physicians\' perceptions about these products or what type of information they share with their patients. This is concerning since physician--patient communication about e-cigarettes may shape patients\' perceptions (e.g., perceived safety) or whether they decide to use e-cigarettes (e.g., switch from cigarettes to e-cigarettes or stop using them because of a doctor\'s warning). More strongly designed research studies are needed on this timely and important issue.
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Physician--patient communication and perceptions regarding e-cigarettes, United States, 2014 (n = 158).

                                                                           Patients asked about e-cigarettes   Recommended e-cigarettes   Endorses harm reduction approach                                                                           
  ------------------------------------------------------------------ ----- ----------------------------------- -------------------------- ---------------------------------- ------- ----------------- -------------------- ------- ---------------- --------------------
  *Time*                                                                                                                                                                                                                                             
  Jan/Feb                                                            73    51.4%                               1.0 (ref)                  1.0 (ref)                          21.4%   1.0 (ref)         1.0 (ref)            26.4%   1.0 (ref)        1.0 (ref)
  Mar/Apr                                                            85    77.1%                               3.2 (1.6--6.4)             **3.0 (1.3--6.8)**                 34.9%   2.0 (0.9--4.1)    1.8 (0.8--4.1)       41.0%   1.9 (1.0--3.9)   1.4 (0.7--3.1)
                                                                                                                                                                                                                                                     
  *Provider type*                                                                                                                                                                                                                                    
  Primary care                                                       62    50.8%                               1.0 (ref)                  1.0 (ref)                          24.1%   1.0 (ref)         1.0 (ref)            23.3%   1.0 (ref)        1.0 (ref)
  Specialist --- tobacco diseases[a](#tf0005){ref-type="table-fn"}   96    74.0%                               2.7 (1.4--5.5)             1.7 (0.8--3.8)                     31.6%   1.5 (0.7--3.1)    1.1 (0.5--2.6)       41.1%   2.3 (1.1--4.8)   1.9 (0.8--4.1)
                                                                                                                                                                                                                                                     
  *Sex*                                                                                                                                                                                                                                              
  Female                                                             44    62.8%                               1.0 (ref)                  1.0 (ref)                          11.6%   1.0 (ref)         1.0 (ref)            18.2%   1.0 (ref)        1.0 (ref)
  Male                                                               112   65.8%                               1.1 (0.5--2.4)             0.8 (0.3--1.9)                     35.8%   4.2 (1.5--11.8)   **3.5 (1.3--9.7)**   40.9%   3.1 (1.3--7.4)   **2.6 (1.0--6.6)**
                                                                                                                                                                                                                                                     
  *Asks/advises smokers to quit*                                                                                                                                                                                                                     
  Less than always                                                   67    51.6%                               1.0 (ref)                  1.0 (ref)                          25.4%   1.0 (ref)         1.0 (ref)            35.9%   1.0 (ref)        1.0 (ref)
  Always                                                             91    74.4%                               2.7 (1.4--5.5)             **2.7 (1.3--5.6)**                 30.3%   1.3 (0.6--2.7)    1.4 (0.6--3.1)       33.7%   0.9 (0.5--1.8)   0.9 (0.5--1.9)
                                                                                                                                                                                                                                                     
  *Graduated med school*                                                                                                                                                                                                                             
  Before 1990                                                        78    61.5%                               1.0 (ref)                  1.0 (ref)                          27.3%   1.0 (ref)         1.0 (ref)            30.8%   1.0 (ref)        1.0 (ref)
  1990--2010                                                         73    68.1%                               1.3 (0.7--2.6)             1.5 (0.7--3.1)                     32.4%   1.3 (0.6--2.6)    1.5 (0.7--3.2)       40.8%   1.6 (0.8--3.1)   1.6 (0.8--3.2)
  Overall                                                            158   64.7%                                                                                             29.7%                                          35.6%                    

Bold-faced values indicate statistical significance at the p \< 0.05 level.

Includes oncologists, cardiologists, and pulmonologists.
